The c-Myc and HES1 are known to be downstream effector molecules of the Notch pathway, and their oncogenic role in the transformation of CML in BC is well-established [8, 10, 11, 38, 39]. Here, HES1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.